Skip to main content

Month: July 2023

Sportradar to Release Second Quarter 2023 Financial Results on August 9, 2023

NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ:SRAD) (“Sportradar”), a leading global technology company focused on enabling next generation engagement in sports by providing business-to-business solutions to the global sports betting industry, will release its financial and operating results for the second quarter ended June 30, 2023 on Wednesday, August 9, 2023. Sportradar will also host an earnings call via webcast to discuss the results at 8:00 a.m. EDT on Wednesday, August 9, 2023. Those wishing to either listen to, or participate in, the earnings webcast can do so by accessing Sportradar’s investor relations website at https://investors.sportradar.com/. Additionally, a replay will be posted on the investor relations site for one year after the conclusion of the event. About SportradarSportradar Group...

Continue reading

BurgerFi International, Inc. CEO, Carl Bachmann Invests in Company

Signals commitment to the brand vision and mission on his first dayCarl Bachmann, CEO of BurgerFi International, Inc. Carl Bachmann, CEO of BurgerFi International, Inc.FORT LAUDERDALE, Fla., July 12, 2023 (GLOBE NEWSWIRE) — On Carl J. Bachmann’s first day as Chief Executive Officer of BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of leading fast-casual brand BurgerFi and the casual dining pizza brand Anthony’s Coal Fired Pizza & Wings, he announced that he has become one of the largest individual management team investors in the company. “I want to signal to our employees, franchisees, and existing investors, my belief and commitment to our brand. I can think of no better way to do so than acquiring shares in the company,” said Carl Bachmann, CEO of BurgerFi International, Inc. Bachmann...

Continue reading

Blue Foundry Bancorp Schedules Second Quarter 2023 Earnings Conference Call

RUTHERFORD, N.J., July 12, 2023 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, July 26, 2023 it will release financial results for the quarter and six months ended June 30, 2023. A copy of the earnings release will be available on the Company’s website, https://ir.bluefoundrybank.com/, in the “News” section and at the SEC’s website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, July 26, 2023 at 11:00AM (ET) to discuss the Second Quarter 2023 and six months earnings. Blue Foundry Bancorp will address live questions from analysts. The conference call will be recorded and will be available on the Company’s website for one month. We encourage participants...

Continue reading

European Commission selects VERSES to help build a Network of Excellence for Artificial Intelligence at the Edge: the dAIEDGE project

VANCOUVER, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in the next generation of artificial intelligence, announces winning a research and innovation grant in the amount of €418,000 from the EU Commission and their Horizon Europe project entitled dAIEDGE , a network of excellence for “distributed, trustworthy, efficient and scalable AI at the Edge.” Artificial intelligence (AI) is becoming a major force in shaping the future of the internet and the world. By combining edge computing and AI (Edge AI), devices can make decisions in a few milliseconds by processing data directly at the point of origin—without insecure connections, high latency, large energy overheads or costs due to transmission....

Continue reading

Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023

MARLBOROUGH, Mass., July 12, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2023 after the market close on Monday, August 7th, 2023. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya Biosciences As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping....

Continue reading

Paulding Ohio Hospital Deploys BIO-key’s PortalGuard® Cloud Platform to Manage Identity-Bound Biometric Authentication for Epic Hyperdrive

PAULDING, Ohio and WALL, N.J., July 12, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced that longstanding customer Paulding County Hospital (PCH) is deploying BIO-key’s PortalGuard® Identity-as-a-Service (IDaaS) cloud platform to leverage its existing investment in BIO-key’s biometric authentication solution as it migrates to Epic Hyperdrive. The new browser-based Epic Hyperdrive electronic health records system is replacing Epic’s legacy Hyperspace application. Recognizing the importance of efficient and secure access to critical healthcare applications, PCH is deploying PortalGuard IDaaS in conjunction with Epic Hyperdrive to extend its use of BIO-key’s biometric...

Continue reading

Orezone Reports Q2-2023 Gold Production

VANCOUVER, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to provide Q2-2023 production results from its Bomboré Gold Mine. Q2-2023 HighlightsGold production of 35,482oz, totalling 76,783oz for H1-2023. Gold sales of 33,608oz at an average realized price of US$1,970/oz resulting in sales of US$66.2M. Senior loan principal repayments of US$19.1M and US$28.8M for Q2-2023 and H1-2023, respectively. Senior loan of US$66.4M remains outstanding. Cash position of US$32.3M as at June 30, 2023.Patrick Downey, President & CEO stated, “Q2 marked another solid quarter at Bomboré, with ore processed continuing to achieve rates beyond nameplate design. Overall mill throughput for the quarter was slightly below that of Q1 due to lower than planned...

Continue reading

Daktronics, Inc. Announces Fiscal Year and Fourth Quarter 2023 Results

BROOKINGS, S.D., July 12, 2023 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ – DAKT) today reported fiscal year and fourth quarter 2023 results. Fiscal 2023 financial highlights:Record sales of $754.2 million for the 2023 fiscal year and $209.9 million for the fourth quarter, up 23.4 percent and 29.4 percent compared to the 2022 fiscal year and fourth quarter, respectively Gross profit levels improved to 20.1 percent of sales for fiscal year 2023 as compared to 19.1 percent of sales for fiscal 2022 and improved to 24.8 percent from 18.5 percent for the fourth quarters of fiscal 2023 and fiscal 2022, respectively Supply chain stabilization and temporary investments in inventory and capacity contributed to more effective and efficient production and order fulfillment starting late in the 2023 second quarter through the end...

Continue reading

Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates

Sudocetaxel zendusortide Phase 1 Trial to resume following FDA agreement to amended protocolQ2 2023 consolidated revenue were affected by specialty pharmacy inventory adjustments, and came in at $17.5 millionFY2023 revenue guidance recast to fall within $82 million and $87 million, or growth in the range of 3% and 9%, as compared to 2022$5.5 million in additional annualized cost savings measures to be implemented, ensures pathway to reaching positive adjusted EBITDAMONTREAL, July 12, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for the second quarter and first half of fiscal year 2023 ended May 31,...

Continue reading

JACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patients

Volume and Pressure Measures are Complementary, Not Interchangeable Oak Ridge, TN, July 12, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces a new research letter in the Journal of the American College of Cardiology – Heart Failure validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. The study, titled “Discordant Pressure-Volume Trends During CardioMEMS Monitoring,” evaluated the correlation of pressure-volume profiles over two time periods in a series of heart failure (HF) patients who underwent CardioMEMS implantation to measure pressure, and direct measurement of total blood volume using Daxor’s blood volume analysis (BVA) diagnostic. Veraprapas Kittipibul M.D., lead investigator...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.